Management guideline for the off-label use of medicine in China (2021).
Zuo W, Sun Y, Liu R, Du L, Yang N, Sun W, Wang P, Tang X, Liu Y, Ma Y, Meng M, Lei R, Yan X, Peng H, Chang Q, Pan H, Zhang B, Chen Y, Zhang S; guideline working group.
Zuo W, et al.
Expert Rev Clin Pharmacol. 2022 Oct;15(10):1253-1268. doi: 10.1080/17512433.2022.2120468. Epub 2022 Sep 11.
Expert Rev Clin Pharmacol. 2022.
PMID: 36047057